VolitionRx Limited Extends Clinical Trial Program in Lung Cancer
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall St rises as AI momentum holds heading into key earnings, Fed decision
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
| VolitionRX Limited (NYSE: VNRX) | Delayed: 0.19 +0.01 (5.56%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.18 | 52 Week High | $5.86 | |||
| Open | $0.19 | 52 Week Low | $3.05 | |||
| Day High | $0.19 | P/E | N/A | |||
| Day Low | $0.16 | EPS | $-0.45 | |||
| Volume | 3,554,883 | |||||
